S. Manfredi, C. Lepage, and C. Hatem, Epidemiology and Management of Liver Metastases From Colorectal Cancer, Annals of Surgery, vol.244, issue.2, pp.254-263, 2006.
DOI : 10.1097/01.sla.0000217629.94941.cf

J. Leporrier, J. Maurel, and L. Chiche, A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer, British Journal of Surgery, vol.231, issue.4, pp.465-74, 2006.
DOI : 10.1016/S0039-6109(16)44790-0

L. Cummings, J. Payes, and G. Cooper, Survival after hepatic resection in metastatic colorectal cancer, Cancer, vol.239, issue.4, pp.718-744, 2007.
DOI : 10.1002/cncr.22448
URL : http://onlinelibrary.wiley.com/doi/10.1002/cncr.22448/pdf

L. Weiss, E. Grundmann, and J. Torhorst, Haematogenous metastastic patterns in colonic carcinoma: An analysis of 1541 necropsies, The Journal of Pathology, vol.2, issue.3, pp.195-203, 1986.
DOI : 10.1007/978-94-009-9158-3_4

J. Scheele, R. Stangl, and A. Altendorf-hofmann, Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history, British Journal of Surgery, vol.162, issue.11, pp.1241-1247, 1990.
DOI : 10.1016/S0039-6109(16)42342-X

M. Choti, J. Sitzmann, and M. Tiburi, Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases, Annals of Surgery, vol.235, issue.6, pp.759-66, 2002.
DOI : 10.1097/00000658-200206000-00002

P. Simmonds, J. Primrose, and J. Colquitt, Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies, British Journal of Cancer, vol.2, issue.7, pp.982-99, 2006.
DOI : 10.1002/path.1711500308

Y. Fong, A. Cohen, and J. Fortner, Liver resection for colorectal metastases., Journal of Clinical Oncology, vol.15, issue.3, pp.938-984, 1997.
DOI : 10.1200/JCO.1997.15.3.938

Y. Nakajima, M. Nagao, and S. Ko, Clinical predictors of recurrence site after hepatectomy for metastatic colorectal cancer, Hepatogastroenterology, vol.48, pp.1680-1684, 2001.

B. Nordlinger, H. Sorbye, and B. Glimelius, Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial, The Lancet, vol.371, issue.9617, pp.1007-1023, 2008.
DOI : 10.1016/S0140-6736(08)60455-9

B. Nordlinger, H. Sorbye, B. Glimelius, G. Poston, P. Schlag et al., Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial, The Lancet Oncology, vol.14, issue.12, pp.1208-1223, 2013.
DOI : 10.1016/S1470-2045(13)70447-9

E. Mitry, A. Fields, and H. Bleiberg, Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials, Journal of Clinical Oncology, vol.26, issue.30, pp.4906-4917, 2008.
DOI : 10.1200/JCO.2008.17.3781
URL : https://hal.archives-ouvertes.fr/hal-00363701

G. Portier, D. Elias, and O. Bouche, Multicenter Randomized Trial of Adjuvant Fluorouracil and Folinic Acid Compared With Surgery Alone After Resection of Colorectal Liver Metastases: FFCD ACHBTH AURC 9002 Trial, Journal of Clinical Oncology, vol.24, issue.31, pp.4976-82, 2006.
DOI : 10.1200/JCO.2006.06.8353
URL : https://hal.archives-ouvertes.fr/hal-00485672

B. Langer, H. Bleiberg, and R. Labianca, Fluorouracil (FU) plus Acide Folinique (I-LV) versus observation after potentially curative resection of liver or lung metastases from colorectal cancer (CRC) : Results of the ENG (EORTC/NCIC CTG/GIVIO) randomized trial, Proc Am Soc Clin Oncol, vol.21, p.149, 2002.

R. Parks, M. Gonen, and N. Kemeny, Adjuvant Chemotherapy Improves Survival after Resection of Hepatic Colorectal Metastases: Analysis of Data from Two Continents, Journal of the American College of Surgeons, vol.204, issue.5, pp.753-76, 2007.
DOI : 10.1016/j.jamcollsurg.2006.12.036

A. Chang, P. Schneider, and P. Sugarbaker, A Prospective Randomized Trial of Regional Versus Systemic Continuous 5-Fluorodeoxyuridine Chemotherapy in the Treatment of Colorectal Liver Metastases, Annals of Surgery, vol.206, issue.6, pp.685-93, 1987.
DOI : 10.1097/00000658-198712000-00001

N. Kemeny, J. Daly, and B. Reichman, Intrahepatic or Systemic Infusion of Fluorodeoxyuridine in Patients with Liver Metastases from Colorectal Carcinoma, Annals of Internal Medicine, vol.107, issue.4, pp.459-65, 1987.
DOI : 10.7326/0003-4819-107-4-459

D. Hohn, R. Stagg, and M. Friedman, A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial., Journal of Clinical Oncology, vol.7, issue.11, pp.1646-54, 1989.
DOI : 10.1200/JCO.1989.7.11.1646

J. Martin, O. Jr, M. Connell, and H. Wieand, Intra-arterial Floxuridine vs Systemic Fluorouracil for Hepatic Metastases From Colorectal Cancer, Archives of Surgery, vol.125, issue.8, pp.1022-1029, 1990.
DOI : 10.1001/archsurg.1990.01410200086013

P. Rougier, A. Laplanche, and M. Huguier, Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial., Journal of Clinical Oncology, vol.10, issue.7, pp.1112-1120, 1992.
DOI : 10.1200/JCO.1992.10.7.1112

T. Allen-mersh, S. Earlam, and C. Fordy, Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases, The Lancet, vol.344, issue.8932, pp.1255-60, 1994.
DOI : 10.1016/S0140-6736(94)90750-1

M. Lorenz and H. Müller, Randomized, Multicenter Trial of Fluorouracil Plus Leucovorin Administered Either Via Hepatic Arterial or Intravenous Infusion Versus Fluorodeoxyuridine Administered Via Hepatic Arterial Infusion in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma, Journal of Clinical Oncology, vol.18, issue.2, pp.243-54, 2000.
DOI : 10.1200/JCO.2000.18.2.243

D. Kerr, C. Mcardle, and J. Ledermann, Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial, The Lancet, vol.361, issue.9355, pp.368-73, 2003.
DOI : 10.1016/S0140-6736(03)12388-4

N. Kemeny, D. Niedzwiecki, and D. Hollis, Hepatic Arterial Infusion Versus Systemic Therapy for Hepatic Metastases From Colorectal Cancer: A Randomized Trial of Efficacy, Quality of Life, and Molecular Markers (CALGB 9481), Journal of Clinical Oncology, vol.24, issue.9, pp.1395-403, 2006.
DOI : 10.1200/JCO.2005.03.8166

T. Kingham, D. Angelica, M. Kemeny, and N. , Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases, Journal of Surgical Oncology, vol.19, issue.8, pp.988-95, 2010.
DOI : 10.1200/JCO.2005.07.100

R. Kelly, N. Kemeny, and G. Leonard, Current Strategies Using Hepatic Arterial Infusion Chemotherapy for the Treatment of Colorectal Cancer, Clinical Colorectal Cancer, vol.5, issue.3, pp.166-74, 2005.
DOI : 10.3816/CCC.2005.n.027

N. Kemeny, W. Jarnagin, and P. Paty, Phase I Trial of Systemic Oxaliplatin Combination Chemotherapy With Hepatic Arterial Infusion in Patients With Unresectable Liver Metastases From Colorectal Cancer, Journal of Clinical Oncology, vol.23, issue.22, pp.4888-96, 2005.
DOI : 10.1200/JCO.2005.07.100

D. Gallagher, M. Capanu, G. Raggio, and N. Kemeny, Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis, Annals of Oncology, vol.18, issue.12, pp.1995-2004, 2007.
DOI : 10.1093/annonc/mdm405

R. Dzodic, G. Gomez-abuin, and P. Rougier, Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model, Anti-Cancer Drugs, vol.15, issue.6, pp.647-50, 2004.
DOI : 10.1097/01.cad.0000131684.06390.fe

I. Guthoff, E. Lotspeich, and C. Fester, Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility, Anticancer Res, vol.23, pp.5203-5211, 2003.

M. Ducreux, M. Ychou, and A. Laplanche, Hepatic Arterial Oxaliplatin Infusion Plus Intravenous Chemotherapy in Colorectal Cancer With Inoperable Hepatic Metastases: A Trial of the Gastrointestinal Group of the F??d??ration Nationale des Centres de Lutte Contre le Cancer, Journal of Clinical Oncology, vol.23, issue.22, pp.4881-4888, 2005.
DOI : 10.1200/JCO.2005.05.120

D. Goéré, I. Deshaies, and T. De-baere, Prolonged Survival of Initially Unresectable Hepatic Colorectal Cancer Patients Treated With Hepatic Arterial Infusion of Oxaliplatin Followed by Radical Surgery of Metastases, Annals of Surgery, vol.251, issue.4, pp.686-91, 2010.
DOI : 10.1097/SLA.0b013e3181d35983

L. Wagman, M. Kemeny, and L. Leong, A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver., Journal of Clinical Oncology, vol.8, issue.11, pp.1885-93, 1990.
DOI : 10.1200/JCO.1990.8.11.1885

N. Lygidakis, N. Ziras, and J. Parissis, Resection versus resection combined with adjuvant pre-and post-operative chemotherapy?immunotherapy for metastatic colorectal livercancer. A new look at an old problem, Hepatogastroenterology, vol.42, pp.155-61, 1995.

M. Lorenz, H. Muller, and H. Schramm, Randomized Trial of Surgery Versus Surgery Followed by Adjuvant Hepatic Arterial Infusion With 5-Fluorouracil and Folinic Acid for Liver Metastases of Colorectal Cancer, Annals of Surgery, vol.228, issue.6, pp.756-62, 1998.
DOI : 10.1097/00000658-199812000-00006

N. Kemeny, Y. Huang, and A. Cohen, Hepatic Arterial Infusion of Chemotherapy after Resection of Hepatic Metastases from Colorectal Cancer, New England Journal of Medicine, vol.341, issue.27, pp.2039-2087, 1999.
DOI : 10.1056/NEJM199912303412702

C. Rudroff, A. Altendorf-hoffmann, and R. Stangl, Prospective randomised trial on adjuvant hepatic-artery infusion chemotherapy after R0 resection of colorectal liver metastases. Langenbeck's Arch Surg, pp.243-252, 1999.
DOI : 10.1007/s004230050199

T. Tono, Y. Hasuike, and H. Ohzato, Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases, Cancer, vol.117, issue.7, pp.1549-56, 2000.
DOI : 10.1007/978-3-642-84138-5_22
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/%28SICI%291097-0142%2820000401%2988%3A7%3C1549%3A%3AAID-CNCR8%3E3.0.CO%3B2-K

N. Lygidakis, G. Sgourakis, and L. Vlachos, Metastatic liver disease of colorectal origin: the value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resection. Results of a prospective randomized study, Hepatogastroenterology, vol.48, pp.1685-91, 2001.

M. Kemeny, S. Adak, and B. Gray, Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy?an intergroup study, J Clin Oncol, vol.20, pp.1499-505, 2002.

R. Nelson and S. Freels, Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver, Cochrane Database Syst Rev, vol.4, p.3770, 2006.

N. Kemeny and M. Gonen, Hepatic Arterial Infusion after Liver Resection, New England Journal of Medicine, vol.352, issue.7, pp.734-739, 2005.
DOI : 10.1056/NEJM200502173520723

M. House, N. Kemeny, and M. Gönen, Comparison of Adjuvant Systemic Chemotherapy With or Without Hepatic Arterial Infusional Chemotherapy After Hepatic Resection for Metastatic Colorectal Cancer, Annals of Surgery, vol.254, issue.6, pp.851-857, 2011.
DOI : 10.1097/SLA.0b013e31822f4f88

S. Alberts, M. Roh, and M. Mahoney, Alternating Systemic and Hepatic Artery Infusion Therapy for Resected Liver Metastases From Colorectal Cancer: A North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) Phase II Intergroup Trial, N9945/CI-66, Journal of Clinical Oncology, vol.28, issue.5, pp.853-861, 2010.
DOI : 10.1200/JCO.2009.24.6728
URL : http://europepmc.org/articles/pmc2834397?pdf=render

B. Nordlinger, M. Guiguet, and J. Vaillant, Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients, Cancer, vol.331, issue.7, pp.1254-62, 1996.
DOI : 10.1001/archsurg.1992.01420050085011

Y. Fong, J. Fortner, and R. Sun, Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer, Annals of Surgery, vol.230, issue.3, pp.309-327, 1999.
DOI : 10.1097/00000658-199909000-00004

S. Iwatsuki, I. Dvorchik, and J. Madariaga, Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system11No competing interests declared., Journal of the American College of Surgeons, vol.189, issue.3, pp.291-300, 1999.
DOI : 10.1016/S1072-7515(99)00089-7

S. Zakaria, J. Donohue, and F. Que, Hepatic Resection for Colorectal Metastases, Annals of Surgery, vol.246, issue.2, pp.183-91, 2007.
DOI : 10.1097/SLA.0b013e3180603039

H. Malik, K. Prasad, and K. Halazun, Preoperative Prognostic Score for Predicting Survival After Hepatic Resection for Colorectal Liver Metastases, Annals of Surgery, vol.246, issue.5, pp.806-820, 2007.
DOI : 10.1097/SLA.0b013e318142d964

M. Rees, P. Tekkis, F. Welsh, T. O-'rourke, and T. John, Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer, Annals of Surgery, vol.247, issue.1, pp.125-160, 2008.
DOI : 10.1097/SLA.0b013e31815aa2c2

D. Goéré, L. Benhaim, and S. Bonnet, Adjuvant Chemotherapy After Resection of Colorectal Liver Metastases in Patients at High Risk of Hepatic Recurrence, Annals of Surgery, vol.257, issue.1, pp.114-134, 2013.
DOI : 10.1097/SLA.0b013e31827b9005

R. Simon, Optimal two-stage designs for phase II clinical trials, Controlled Clinical Trials, vol.10, issue.1, pp.1-10, 1989.
DOI : 10.1016/0197-2456(89)90015-9